Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue
Upal Roy,1,* Hong Ding,1,* Sudheesh Pilakka-Kanthikeel,1 Andrea D Raymond,1 Venkata Atluri,1 Adriana Yndart,1 Elena M Kaftanovskaya,2 Elena Batrakova,3 Marisela Agudelo,1 Madhavan Nair1 1Center for Personalized NanoMedicine, Institute of NeuroImmune Pharmacology, Department of Immunology, 2Departme...
Guardado en:
Autores principales: | Roy U, Ding H, Pilakka-Kanthikeel S, Raymond AD, Atluri V, Yndart A, Kaftanovskaya EM, Batrakova E, Agudelo M, Nair M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef83accdfa1e4a3da362c3d0295cf6c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection
por: Atluri VSR, et al.
Publicado: (2016) -
Nanodrugs: pharmacokinetics and safety
por: Onoue S, et al.
Publicado: (2014) -
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari S, et al.
Publicado: (2019) -
Critical evaluation of biodegradable polymers used in nanodrugs
por: Marin E, et al.
Publicado: (2013) -
Nanodrugs: optimism for emerging trend of multidrug resistance
por: Khan AU
Publicado: (2012)